BCP-ALL cells can be distinguished from normal B-cells by abnormal expression of known maturation makers (e.g., CD10, CD20, CD34, and CD45) combined with aberrant expression of other markers (e.g., CD58, CD81, CD304, CD73, CD66c, and CD123). Here, NRP1 is linked to acute lymphoblastic leukemia.